A Life-style Physical Activity Intervention and the Antibody Response to Pneumococcal Vaccination in Women
Overview
Authors
Affiliations
Objective: To assess whether a life-style physical activity intervention improved antibody response to a pneumococcal vaccination in sedentary middle-aged women.
Methods: Eighty-nine sedentary women completed a 16-week exercise (physical activity consultation, pedometer, telephone/e-mail prompts; n = 44) or control (advisory leaflet; n = 45) intervention. Pneumococcal vaccination was administered at 12 weeks, and antibody titers (11 of the 23 contained in the pneumococcal vaccine) were determined before vaccination and 4 weeks and 6 months later. Physical activity, aerobic fitness, body composition, and psychological factors were measured before and after the intervention.
Results: The intervention group displayed a greater increase in walking behavior (from mean [standard deviation] = 82.16 [90.90] to 251.87 [202.13]) compared with the control condition (111.67 [94.64] to 165.16 [117.22]; time by group interaction: F(1,68) = 11.25, p = .001, η(2) = 0.14). Quality of life also improved in the intervention group (from 19.37 [3.22] to 16.70 [4.29]) compared with the control condition (19.97 [4.22] to 19.48 [5.37]; time by group interaction: F(1,66) = 4.44, p = .039, η(2) = 0.06). However, no significant effects of the intervention on antibody response were found (time by group η(2) for each of the 11 pneumococcal strains ranged from 0.001 to 0.018; p values all >.264).
Conclusions: Participation in a life-style physical activity intervention increased subjective and objective physical activity levels and quality of life but did not affect antibody response to pneumococcal vaccination.
Dunbar S Front Cell Infect Microbiol. 2023; 13:1296665.
PMID: 38035336 PMC: 10684963. DOI: 10.3389/fcimb.2023.1296665.
Whittaker A, De Nys L, Brindle R, Drayson M Brain Behav Immun Health. 2023; 32:100661.
PMID: 37456624 PMC: 10344668. DOI: 10.1016/j.bbih.2023.100661.
Arigo D, Romano K, Pasko K, Travers L, Ainsworth M, Jackson D Front Psychol. 2022; 13:855749.
PMID: 36211932 PMC: 9534296. DOI: 10.3389/fpsyg.2022.855749.
Dinas P, Koutedakis Y, Ioannou L, Metsios G, Kitas G Vaccines (Basel). 2022; 10(5).
PMID: 35632525 PMC: 9146578. DOI: 10.3390/vaccines10050769.
Matryba P, Gawalski K, Ciesielska I, Horvath A, Bartoszewicz Z, Sienko J Vaccines (Basel). 2022; 10(3).
PMID: 35335074 PMC: 8954058. DOI: 10.3390/vaccines10030443.